Intelligent Bio Solutions (INBS) Competitors $1.47 -0.11 (-6.96%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$1.51 +0.04 (+2.72%) As of 08/1/2025 07:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock INBS vs. NMTC, TMDIF, MODD, MLSS, NEPH, PYPD, POCI, COCH, PSTV, and VVOSShould you be buying Intelligent Bio Solutions stock or one of its competitors? The main competitors of Intelligent Bio Solutions include NeuroOne Medical Technologies (NMTC), Titan Medical (TMDIF), Modular Medical (MODD), Milestone Scientific (MLSS), Nephros (NEPH), PolyPid (PYPD), Precision Optics (POCI), Envoy Medical (COCH), Plus Therapeutics (PSTV), and Vivos Therapeutics (VVOS). These companies are all part of the "medical equipment" industry. Intelligent Bio Solutions vs. Its Competitors NeuroOne Medical Technologies Titan Medical Modular Medical Milestone Scientific Nephros PolyPid Precision Optics Envoy Medical Plus Therapeutics Vivos Therapeutics NeuroOne Medical Technologies (NASDAQ:NMTC) and Intelligent Bio Solutions (NASDAQ:INBS) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, profitability, media sentiment, valuation, risk, dividends and analyst recommendations. Is NMTC or INBS more profitable? NeuroOne Medical Technologies has a net margin of -75.41% compared to Intelligent Bio Solutions' net margin of -319.85%. Intelligent Bio Solutions' return on equity of -176.55% beat NeuroOne Medical Technologies' return on equity.Company Net Margins Return on Equity Return on Assets NeuroOne Medical Technologies-75.41% -334.64% -124.42% Intelligent Bio Solutions -319.85%-176.55%-93.89% Do institutionals and insiders hold more shares of NMTC or INBS? 16.1% of NeuroOne Medical Technologies shares are owned by institutional investors. Comparatively, 33.0% of Intelligent Bio Solutions shares are owned by institutional investors. 8.9% of NeuroOne Medical Technologies shares are owned by company insiders. Comparatively, 1.5% of Intelligent Bio Solutions shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Which has stronger valuation and earnings, NMTC or INBS? Intelligent Bio Solutions has lower revenue, but higher earnings than NeuroOne Medical Technologies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNeuroOne Medical Technologies$3.45M10.95-$12.32M-$0.22-3.45Intelligent Bio Solutions$2.94M3.46-$10.16MN/AN/A Does the media favor NMTC or INBS? In the previous week, NeuroOne Medical Technologies had 2 more articles in the media than Intelligent Bio Solutions. MarketBeat recorded 3 mentions for NeuroOne Medical Technologies and 1 mentions for Intelligent Bio Solutions. NeuroOne Medical Technologies' average media sentiment score of 0.00 equaled Intelligent Bio Solutions'average media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NeuroOne Medical Technologies 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Intelligent Bio Solutions 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts recommend NMTC or INBS? NeuroOne Medical Technologies currently has a consensus price target of $1.45, suggesting a potential upside of 91.29%. Given NeuroOne Medical Technologies' stronger consensus rating and higher possible upside, research analysts plainly believe NeuroOne Medical Technologies is more favorable than Intelligent Bio Solutions.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NeuroOne Medical Technologies 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Intelligent Bio Solutions 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more volatility and risk, NMTC or INBS? NeuroOne Medical Technologies has a beta of 0.68, suggesting that its share price is 32% less volatile than the S&P 500. Comparatively, Intelligent Bio Solutions has a beta of 4.6, suggesting that its share price is 360% more volatile than the S&P 500. SummaryNeuroOne Medical Technologies beats Intelligent Bio Solutions on 8 of the 13 factors compared between the two stocks. Get Intelligent Bio Solutions News Delivered to You Automatically Sign up to receive the latest news and ratings for INBS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding INBS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INBS vs. The Competition Export to ExcelMetricIntelligent Bio SolutionsMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$10.92M$7.18B$5.48B$9.52BDividend YieldN/A2.90%4.73%4.08%P/E RatioN/A64.1328.6723.80Price / Sales3.4634.25373.5466.64Price / CashN/A25.7735.4557.96Price / Book0.628.618.275.55Net Income-$10.16M$239.96M$3.24B$259.03M7 Day Performance-8.70%-5.48%-3.69%-4.59%1 Month Performance-19.67%-3.73%4.33%4.46%1 Year Performance19.51%18.27%25.95%18.03% Intelligent Bio Solutions Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INBSIntelligent Bio Solutions0.5811 of 5 stars$1.47-7.0%N/A+9.7%$10.92M$2.94M0.0010NMTCNeuroOne Medical Technologies1.7095 of 5 stars$0.85-3.9%$1.45+70.2%+5.4%$44.17M$3.45M-3.8720News CoverageShort Interest ↑TMDIFTitan MedicalN/A$0.37flatN/A+934.6%$42.24M$17.63M-0.3050MODDModular Medical0.4917 of 5 stars$0.70-2.0%N/A-53.0%$38.73MN/A-1.3720MLSSMilestone Scientific2.0203 of 5 stars$0.49-17.4%$1.25+156.6%-55.5%$38.23M$8.61M-6.9630News CoverageNEPHNephros1.7144 of 5 stars$3.60+0.8%$5.00+38.9%+52.6%$38.16M$15.52M51.4430News CoveragePositive NewsUpcoming EarningsPYPDPolyPid2.2788 of 5 stars$3.64-1.1%$11.80+224.2%-6.6%$37.50MN/A-0.8580POCIPrecision Optics0.1983 of 5 stars$4.70-2.1%N/A-23.8%$36.80M$19.10M-5.2880Gap UpCOCHEnvoy Medical1.9376 of 5 stars$1.53-1.9%$9.25+504.6%-37.2%$33.27M$220K-1.1134News CoveragePositive NewsEarnings ReportPSTVPlus Therapeutics2.1804 of 5 stars$0.58+9.4%$10.83+1,768.8%-67.5%$32.05M$5.82M-0.2020Gap UpVVOSVivos Therapeutics0.6965 of 5 stars$4.72-9.9%$4.82+2.0%+138.7%$30.86M$14.63M-2.73160Analyst UpgradeShort Interest ↑Gap Down Related Companies and Tools Related Companies NMTC Competitors TMDIF Competitors MODD Competitors MLSS Competitors NEPH Competitors PYPD Competitors POCI Competitors COCH Competitors PSTV Competitors VVOS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:INBS) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intelligent Bio Solutions Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Intelligent Bio Solutions With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
